As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: August 12, 2019
by Chrissy Sexton for Earth.com:
Among patients with Alzheimer’s, excessive daytime napping is often observed long before memory problems are apparent. Prior research has suggested that daytime fatigue results from the poor nighttime sleep associated with Alzheimer’s, while other studies have proposed that abnormal sleeping patterns contribute to the progression of the disease itself.
But now, a study from UC San Francisco has identified a surprising new biological explanation for this phenomenon. The experts discovered that Alzheimer’s disease directly attacks brain regions responsible for wakefulness during the day.
The team demonstrated that these brain regions are among the first to be impacted by the neurodegenerative effects of Alzheimer’s disease. With this in mind, excessive daytime napping could serve as an early indication that the disease is developing, especially in the absence of significant nighttime sleep issues.
The early damage to the brain’s wakefulness center was found to be caused by a protein known as tau, which adds to a growing collection of evidence that tau contributes more directly to neurodegeneration than the more extensively studied amyloid protein.
Study senior author Dr. Lea T. Grinberg is an associate professor of Neurology and Pathology at the UCSF Memory and Aging Center and a member of the Global Brain Health Institute.
“Our work shows definitive evidence that the brain areas promoting wakefulness degenerate due to accumulation of tau – not amyloid protein – from the very earliest stages of the disease,” said Dr. Grinberg.
The investigation was focused on data from the UCSF Neurodegenerative Disease Brain Bank for 13 deceased Alzheimer’s patients and seven healthy control subjects. The researchers measured tau protein levels and neuron numbers in three relevant brain regions.
The study revealed that Alzheimer’s patients had significant tau buildup in all three wakefulness-promoting brain centers that were examined, including the locus coeruleus (LC), lateral hypothalamic area (LHA), and tuberomammillary nucleus (TMN). In addition, these regions had lost up to 75 percent of their neurons.
“It’s remarkable because it’s not just a single brain nucleus that’s degenerating, but the whole wakefulness-promoting network,” said study lead author Jun Oh. “Crucially this means that the brain has no way to compensate because all of these functionally related cell types are being destroyed at the same time.”
The results support earlier findings by Dr. Grinberg’s team that deceased individuals with elevated levels of tau protein in their brainstem, an early characteristic of Alzheimer’s disease, had already begun to experience mood changes and increased sleep disturbances.
“Our new evidence for tau-linked degeneration of the brain’s wakefulness centers provides a compelling neurobiological explanation for those findings,” said Dr. Grinberg. “It suggests we need to be much more focused on understanding the early stages of tau accumulation in these brain areas in our ongoing search for Alzheimer’s treatments.”
The study is published in the journal Alzheimer’s and Dementia.
Depression, stroke and dementia are twice as common in women as in men. Among Alzheimer’s patients, 70 per cent are female. But according to Lynn Posluns, the driving force behind the first “Women’s Brain...
Women are twice as likely as men to develop dementia and almost 70 per cent of new Alzheimer’s patients will be women, yet research has traditionally focused on men. Women’s Brain Health Initiative (WBHI) wants...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.